Xuhao Ni

1.3k total citations · 1 hit paper
16 papers, 967 citations indexed

About

Xuhao Ni is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xuhao Ni has authored 16 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Xuhao Ni's work include Immune Cell Function and Interaction (5 papers), Adenosine and Purinergic Signaling (3 papers) and Peptidase Inhibition and Analysis (3 papers). Xuhao Ni is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Adenosine and Purinergic Signaling (3 papers) and Peptidase Inhibition and Analysis (3 papers). Xuhao Ni collaborates with scholars based in China, United States and Taiwan. Xuhao Ni's co-authors include Fan Pan, Ling Lu, Debangshu Samanta, Cynthia A. Zahnow, Gregg L. Semenza, Edward Gabrielson, Youngrok Park, Huili Li, Xuehao Wang and Jian Gu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Xuhao Ni

16 papers receiving 961 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemotherapy induces enrichment of CD47 ⁺ /CD73 ⁺ /PDL1 ⁺ immune evasive triple-negative breast cancer cells

2018 244 citations Debangshu Samanta, Youngrok Park et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuhao Ni China	12	411	391	273	251	119	16	967
Susana García‐Silva Spain	17	294 0.7×	634 1.6×	283 1.0×	206 0.8×	62 0.5×	24	1.2k
Shunsuke Kitajima Japan	17	442 1.1×	606 1.5×	484 1.8×	289 1.2×	66 0.6×	29	1.2k
Honghong Sun China	16	699 1.7×	760 1.9×	299 1.1×	260 1.0×	63 0.5×	39	1.3k
Victoire Gouirand United States	8	302 0.7×	404 1.0×	286 1.0×	410 1.6×	71 0.6×	10	892
Je-In Youn United States	8	1.3k 3.1×	489 1.3×	622 2.3×	309 1.2×	50 0.4×	9	1.7k
Y. Jeffrey Chiang United States	16	236 0.6×	632 1.6×	217 0.8×	88 0.4×	66 0.6×	22	1.1k
Aude Mallavialle France	15	184 0.4×	409 1.0×	337 1.2×	161 0.6×	104 0.9×	23	791
Gaia Barisione Italy	12	452 1.1×	268 0.7×	294 1.1×	97 0.4×	57 0.5×	16	808
Sugandha Saxena United States	14	407 1.0×	228 0.6×	438 1.6×	103 0.4×	64 0.5×	28	832
Martin Nurmik Luxembourg	5	125 0.3×	411 1.1×	358 1.3×	335 1.3×	47 0.4×	7	788

Countries citing papers authored by Xuhao Ni

Since Specialization

Citations

This map shows the geographic impact of Xuhao Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuhao Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuhao Ni more than expected).

Fields of papers citing papers by Xuhao Ni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuhao Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuhao Ni. The network helps show where Xuhao Ni may publish in the future.

Co-authorship network of co-authors of Xuhao Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Xuhao Ni. A scholar is included among the top collaborators of Xuhao Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuhao Ni. Xuhao Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wu, Xiao, Jianhui Li, Xiyu Wang, et al.. (2023). SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. Cell Death and Differentiation. 30(7). 1742–1756. 11 indexed citations

Wu, Xiao, et al.. (2022). ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer. Cancer Letters. 544. 215802–215802. 19 indexed citations

Huang, Chen‐Song, Qiong‐Cong Xu, Siyun Chen, et al.. (2022). YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation. Clinical and Translational Medicine. 12(6). e848–e848. 48 indexed citations

Peng, Hao, Rong Xue, Jiannan Qiu, et al.. (2020). Cancer-associated fibroblasts enhance the chemoresistance of CD73+ hepatocellular carcinoma cancer cells via HGF-Met-ERK1/2 pathway. Annals of Translational Medicine. 8(14). 856–856. 40 indexed citations

Ni, Xuhao, Yongxiang Xia, Shun Zhou, et al.. (2019). Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways. Cell Death and Disease. 10(1). 13–13. 22 indexed citations

Ni, Xuhao, Jin‐Hui Tao, Joseph Barbi, et al.. (2018). YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity. Cancer Discovery. 8(8). 1026–1043. 168 indexed citations

Zhu, Qiang, Han Wang, Bin Jiang, et al.. (2018). Loss of ATF3 exacerbates liver damage through the activation of mTOR/p70S6K/ HIF-1α signaling pathway in liver inflammatory injury. Cell Death and Disease. 9(9). 910–910. 49 indexed citations

Han, Guoyong, Long Zhang, Xuhao Ni, et al.. (2018). MicroRNA-873 Promotes Cell Proliferation, Migration, and Invasion by Directly Targeting TSLC1 in Hepatocellular Carcinoma. Cellular Physiology and Biochemistry. 46(6). 2261–2270. 23 indexed citations

Samanta, Debangshu, Youngrok Park, Xuhao Ni, et al.. (2018). Chemotherapy induces enrichment of CD47 ⁺ /CD73 ⁺ /PDL1 ⁺ immune evasive triple-negative breast cancer cells. Proceedings of the National Academy of Sciences. 115(6). E1239–E1248. 244 indexed citations breakdown →

10.

Wang, Kunpeng, Jian Gu, Xuhao Ni, et al.. (2016). CD25 signaling regulates the function and stability of peripheral Foxp3+ regulatory T cells derived from the spleen and lymph nodes of mice. Molecular Immunology. 76. 35–40. 10 indexed citations

11.

Gu, Jian, Xuhao Ni, Xiongxiong Pan, et al.. (2016). Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions. Cellular and Molecular Immunology. 14(6). 521–528. 159 indexed citations

12.

Lu, Yunjie, Keli L. Hippen, Jian Gu, et al.. (2016). miR-146b antagomir–treated human Tregs acquire increased GVHD inhibitory potency. Blood. 128(10). 1424–1435. 51 indexed citations

13.

Yang, Huang‐Yu, Joseph Barbi, Ying Zheng, et al.. (2016). MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor. Immunity. 45(1). 83–93. 77 indexed citations

14.

Wang, Qi, Xiongxiong Pan, Qin Zhu, et al.. (2015). Expression of receptor activator of nuclear factor-κB ligand is related to sex differences in collagen-induced arthritis. International Immunopharmacology. 28(2). 892–896. 1 indexed citations

15.

Zhao, Jie, Ye Fan, Kunpeng Wang, et al.. (2015). LncRNA HULC affects the differentiation of Treg in HBV-related liver cirrhosis. International Immunopharmacology. 28(2). 901–905. 36 indexed citations

16.

Yang, Haojun, Jian Gu, Qin Zhu, et al.. (2015). Protection of acute GVHD by all-trans retinoic acid through suppression of T cell expansion and induction of regulatory T cells through IL-2 signaling. International Immunopharmacology. 28(2). 911–916. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact